Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1990
05/08/1990CA1268898A1 Growth hormone-releasing peptides and method of treating mammals therewith
05/08/1990CA1268897A1 Gonadoliberin derivatives and process for the preparation thereof
05/08/1990CA1268711A1 Composition for alleviating cystic fibrosis
05/07/1990CA2002352A1 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
05/07/1990CA2002261A1 High molecular weight human angiogenic factors
05/03/1990WO1990004788A1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants
05/03/1990WO1990004642A1 Method for isolating glycosylated interleukine-2 and glycosylated interleukine-2
05/03/1990WO1990004641A1 FILAMENTOUS HEMAGGLUTININ OF $i(B. PERTUSSIS)
05/03/1990WO1990004635A1 Thrombolytic agents with modified kringle domains
05/03/1990WO1990004634A1 Monoclonal antibodies against receptor-induced binding sites
05/03/1990WO1990004606A1 A process for fractionating polyethylene glycol (peg)-protein adducts and an adduct of peg and granulocyte-macrophage colony stimulating factor
05/03/1990WO1990004605A1 Calcitonin gene related peptide analogues
05/03/1990WO1990004417A1 Methods of and compositions for diagnosing, monitoring and treating the early stages of osteoarthritis
05/03/1990WO1990004415A1 Anti-idiotypic antibody induction of antitumor response
05/03/1990WO1990004414A1 Conjugates of soluble t4 proteins and toxins and methods for treating or preventing aids, arc and hiv infection
05/03/1990WO1990004413A1 ANTIBODY CONJUGATES WITH TWO OR MORE COVALENTLY LINKED Fc REGIONS
05/03/1990WO1990004412A1 Liposome immunoadjuvants containing il-2
05/03/1990WO1990004410A1 A novel family of high affinity, modified antibodies for cancer treatment
05/03/1990WO1990004409A1 Human leukocyte elastase inhibitors and methods of producing and using same
05/03/1990WO1990004408A1 Composition and treatment with biologically active peptides and certain anions
05/03/1990WO1990004407A1 Cpf peptide compositions and uses
05/03/1990WO1990004406A1 Drug containing a glycosylated interleukine-2
05/03/1990WO1990004405A1 Antiviral agent
05/03/1990WO1990004404A1 Gynaecological procedure
05/03/1990WO1990004392A1 Method to improve survival of patients during sepsis by diet composition
05/03/1990WO1990004388A1 In vivo neurotrophic cytoprotective alcohols
05/03/1990WO1990004386A1 Orally pharmaceutical preparations with colon selective delivery
05/03/1990WO1990003181A3 Peptide antagonists for use in cancer therapy, and the use of mas oncogene and its product
05/03/1990DE3935517A1 Ophthalmische zubereitungen enthaltend ein cyclosporin Ophthalmic preparations containing a cyclosporin
05/02/1990EP0366638A2 Neuromodulatory peptide
05/02/1990EP0366621A1 Orally pharmaceutical preparations with colon selective delivery
05/02/1990EP0366532A1 Medical preparations containing glycosylated interleukin-2
05/02/1990EP0366397A1 Novel bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin
05/02/1990EP0366277A2 Pharmaceutical formulations
05/02/1990EP0366091A2 Muteins of a tissue plasminogen activator with duplicated domains
05/02/1990EP0366043A1 Monoclonal antibody
05/02/1990EP0366033A2 Method of improving post-ischemic myocardial dysfunction using an ace inhibitor alone or in combination with a thrombolytic agent and combination
05/02/1990EP0366016A2 Endothelin DNA and use thereof
05/02/1990EP0365997A2 A novel family of high affinity, modified antibodies for cancer treatment
05/02/1990EP0365992A1 Heterocyclic peptide renin inhibitors
05/02/1990EP0365956A2 Carcinostatic agents
05/02/1990EP0365837A2 Intercellular adhesion molecules, and their binding ligands
05/02/1990EP0365779A2 Cyclic GRF-analogs II
05/02/1990EP0365705A1 Biopreparation for the treatment of wounds
05/02/1990EP0365704A1 Biopreparation for the hemostasis in stomach bleedings
05/02/1990EP0365657A1 Dna encoding androgen receptor protein
05/02/1990EP0365656A1 Prophylactic and therapeutic methods for treating edema with phallotoxins
05/02/1990EP0365643A1 Compounds for diagnosis and/or therapy of tumours
05/02/1990EP0365568A1 Proteins and derivatives thereof
05/02/1990EP0197149B1 Method of obtaining human leukocytic interferon
05/02/1990CA2002130A1 Method for the treatment of periodontal disease
05/01/1990US4921841 Immunoaffinity purification of phytolaccin proteins and their use in treating Herpes Simplex virus type II
05/01/1990US4921837 Treatment of AIDS-type disease
05/01/1990US4921835 Method of treating asthma
05/01/1990US4921710 Method of converting cholesterol in food to coprostanol
05/01/1990US4921699 Polypeptides having interferon activity
05/01/1990US4921698 Polypeptide having gamma-interferon activity lacking amino acids coded by exon 4
05/01/1990US4921697 IFN-gamma as an active substance for inhibiting and preventing degradation processes in bone
05/01/1990US4921667 Method for augmenting immune response
05/01/1990CA2001897A1 Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
05/01/1990CA2001884A1 Treatment of genital warts with a combination of liquid nitrogen and recombinant dna human alpha interferon
05/01/1990CA2000887A1 Thromboresistant materials and methods for making same
05/01/1990CA1268597A1 Diamino acid derivatives
05/01/1990CA1268417A1 Intragonadal regulatory protein
04/1990
04/30/1990CA2001911A1 Albumin preparation and process for preparing the same
04/30/1990CA2001787A1 Modified interleukin-2 and production thereof
04/30/1990CA2001771A1 Sequence specific gene repressor
04/29/1990CA2000717A1 Process for producing hemoglobin concentrate
04/28/1990CA2345497A1 Growth hormone variants and method for forming growth hormone variants
04/27/1990CA2001629A1 Human leukocyte elastase inhibitors and methods of producing and using same
04/27/1990CA2001498A1 Neuromodulatory peptide
04/27/1990CA2001494A1 Carcinostatic agents
04/27/1990CA2001343A1 Thrombolytic agents with modified kringle domains
04/26/1990CA2001502A1 Cyclosporin ophthalmic compositions
04/26/1990CA2001292A1 Isolation and cloning of complementary dna for gene coding of bovine trophoblast protein-1
04/25/1990EP0365468A1 Pharmaceutically active combination comprising a plasminogen activator and hirudin
04/25/1990EP0365319A2 Glycopeptide antibiotics
04/25/1990EP0365134A1 Synergistic compositions of renal dopaminergic agent and angiotensin converting enzyme inhibitors
04/25/1990EP0365045A1 Perhydrothiazepine derivatives, their preparation and their therapeutic use
04/25/1990EP0365044A2 Novel pharmaceutical use of (NVA)2-cyclosporine
04/25/1990EP0364980A2 Colony stimulating factor-gelatin conjugate
04/25/1990EP0364942A2 Isohirudine
04/25/1990EP0364819A2 LHRH analogs
04/25/1990EP0364690A2 The alpha-subunit of the Mac-1 leukocyte adhesion receptor
04/25/1990EP0364561A1 FACTOR VII/VIIa ACTIVE SITE INHIBITORS
04/25/1990EP0364509A1 Cellular toxic conjugates
04/25/1990EP0364493A1 Renin inhibiting peptides with nonpeptide linkages
04/25/1990EP0364491A1 Stabilized formulations of gamma interferons
04/25/1990EP0364481A1 Growth factors
04/25/1990EP0163723B1 Ddavp antidiuretic and method therefor
04/25/1990CA2001333A1 Gynaecological procedure
04/24/1990US4920196 Human lymphotoxin
04/24/1990US4920194 Blood substitute
04/24/1990US4920144 Derivatives of bicyclic amino acids, agents containing them and their use as hypotensives
04/24/1990US4919927 Using ammonium chloride
04/24/1990US4919917 Administering organogermanium compound
04/24/1990CA2001373A1 Methods and compositions for diagnosing, monitoring and treating the early stage of osteoarthritis
04/24/1990CA2000469A1 Method of improving post-ischemic myocardial dysfunction using and ace inhibitor alone or in combination with a thrombolytic agent and combination
04/24/1990CA1268300A1 Method of somatotropin solubilization and naturation
04/21/1990CA2001150A1 Composition and treament with biologically active peptides and certain anions